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A B S T R A C T
Sex and gender influence health differently. Associations between sex and health have been extensively studied,
but gender (i.e. psychosocial sex) has been largely neglected, partly due to the absence of gender measures in
cohort studies. Therefore, our objective was to test the unique associations of gender and sex with common
somatic symptoms and chronic diseases, using a gender index created from existing cohort data. We applied
LASSO logistic regression to identify, out of 153 unique variables, psychosocial variables that were predictive of
sex (i.e. gender-related) in the Dutch LifeLines Cohort Study. These psychosocial variables covered gender roles
and institutionalized gender. Using the estimated coefficients, gender indexes were calculated for each adult
participant in the study (n = 152,728; 58.5% female; mean age 44.6 (13.1) years). We applied multiple ordinal
and logistic regression to test the unique associations of the gender index and sex, and their interactions, with
common somatic symptoms assessed by the SCL-90 SOM and self-reported lifetime prevalence of chronic dis-
eases, respectively. We found that in 10.1% of the participants the gender index was not in line with participants’
sex: 12.5% of men and 8.4% of women showed a discrepancy between gender index and sex. Feminine gender
characteristics are associated with increased common somatic symptoms and chronic diseases, especially in men.
Female sex is associated with a higher common somatic symptom burden, but not with a higher prevalence of
chronic diseases. The study shows that gender and sex uniquely impact health, and should be considered in
epidemiological studies. Our methodology shows that consideration of gender measures in studies is necessary
and feasible, based on data generally present in cohort studies.
Sex and gender are increasingly recognized as essential aspects
within health research (Pardue and Wizemann, 2001; Phillips, 2011;
Springer et al., 2012). Sex differences in the distribution and pre-
sentation of common somatic symptoms and medical conditions have
been found, including in cardiovascular disease and depression, as well
as in responses to treatments of these (Labaka et al., 2018; Spence and
Pilote, 2015; Tomenson et al., 2013). However, gender differences re-
main largely neglected in health research (Nowatzki and Grant, 2011).
This is problematic, as evidence suggests that studying the roles of both
sex and gender may reveal additional insights into their respective
contribution in disease development, help-seeking behavior and re-
sponse to treatment (Nowatzki and Grant, 2011; Phillips, 2011; Smith
and Koehoorn, 2013).
To understand the importance of incorporating gender into health
research, one should clearly distinguish between the concepts of sex
and gender. Biological sex is defined as one's biological attributes, in-
cluding physical features, chromosomes, gene expression, hormones
and anatomy (Johnson et al., 2007). Yet, intersex variations exist in
approximately 1.7% of the general population, challenging beliefs in
absolute dimorphisms (Blackless et al., 2000). Gender, in contrast, can
be seen as the psychosocial equivalent of biological sex: it encompasses
the socially constructed roles, behaviors, identities and relationships of
women, men and gender-diverse people in a given time and society
(Smith and Koehoorn, 2013). In short, gender has a broader scope than
sex and often refers to socially prescribed roles and behaviors, and
experienced dimensions that relate to femininity and masculinity
(Bottorff et al., 2011). In general, gender roles, and the embodiment
hereof, are not as static as one's biological sex usually is. They are
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subjected to ever-changing societal norms and institutions and may
impact one's opportunities in life (Johnson et al., 2007).
Examples of differing associations of sex and gender roles with
health can be found in multiple common medical conditions. For ex-
ample, it is known that females develop osteoporosis more frequently
due to biological differences in bone density and hormone levels
(Alswat, 2017). Simultaneously, gender roles may encourage females
(and feminine males) to restrict their food intake and perform sports not
involving heavy weightlifting, further increasing their risk of devel-
oping osteoporosis (Noh et al., 2018). Another example can be seen in
healthcare seeking behavior and treatment allocation (Galdas et al.,
2005). Masculine gender roles may affect help-seeking behavior and
hamper adequate diagnosis and treatment, for example in depressive
symptoms, as masculine gender roles are thought to be less expressive
and to not openly acknowledge pain or impairments compared to
feminine gender roles (Barsky et al., 2001; Lee and Owens, 2002).
Disentangling associations of sex and gender with health may enhance
our insights towards effective medicine in a given society.
Although the association of sex with health is often incorporated,
the association of gender roles with health is seldom considered in re-
search (Nowatzki and Grant, 2011; Tannenbaum et al., 2019). There-
fore, little is known about whether sex and gender roles uniquely as-
sociate with symptoms and diagnoses. Similarly, whether these
associations are present amongst a variety of health issues or merely
specific symptoms, and whether associations differ between women and
men, remains unknown. These gaps in knowledge may be attributable
to difficulties in measuring gender. Existing gender measures, such as
the Bem Sex Role Inventory (BSRI) (Bem, 1974; Hoffman and Borders,
2001), Personal Attributes Questionnaire (PAQ) (Helmreich et al.,
1981) and gender diagnosticity measures (Lippa and Connelly, 1990)
have been extensively criticized. These instruments measure gender via
items that stereotype masculine and feminine characteristics, whilst
gender roles are a broader concept largely dependent on time and place
(Choi et al., 2008; Hoffman and Borders, 2001; Pedhazur; Tetenbaum,
1979). Possibly due to these difficulties, most epidemiological cohort
studies do not measure gender in any way.
To the best of our knowledge, we present the first comprehensive
analyses of the associations of sex and gender with health in a large
epidemiological study: the general population cohort LifeLines. To this
end, we constructed a gender index based on the existing data. We
hypothesized that sex and the gender index will have a unique asso-
ciation with common somatic symptoms, as well as the lifetime pre-
valence of chronic disease. We also expected that female sex and fem-
inine gender indexes will be associated with higher symptom levels and
lifetime prevalence of chronic disease and that the associations of
gender differ per sex.
1. Methods
1.1. Participants
This study was performed in LifeLines. Lifelines is a multi-dis-
ciplinary prospective population-based cohort study examining in a
unique three-generation design the health and health-related behaviors
of 167,729 persons living in the North of The Netherlands. It employs a
broad range of investigative procedures in assessing the biomedical,
socio-demographic, behavioral, physical and psychological factors
which contribute to the health and disease of the general population,
with a special focus on multi-morbidity and complex genetics.
Extensive information on the cohort and recruitment is provided else-
where (Klijs et al., 2015; Scholtens et al., 2015). The current study was
based on the 152,728 adults included at baseline (Table 1). The Life-
Lines Cohort Study is performed according to the principles of the
Declaration of Helsinki and in accordance with UMCG's research code.
The LifeLines Cohort Study is approved by the Medical Ethical Com-
mittee of the University Medical Center Groningen, The Netherlands.
1.2. Collected data
At baseline, participants completed questionnaires on topics in-
cluding, but not limited to demographics, health, lifestyle and psy-
chosocial aspects. Additionally, participants underwent physical ex-
aminations and biological samples, including DNA, were collected
(Scholtens et al., 2015). DNA material of 15,000 participants (9.8% of
participating adults) was analyzed with 12-sample HumanCytoSNP-12
BeadChips. Quality control measures included i) exclusion of material
with a call-rate< 95%, ii) duplicate material, iii) chromosome X het-
erozygosity was>0.005 (for municipally-registered males) or chro-
mosome X heterozygosity was<0.1 (for municipally-registered fe-
males), and iv) material when sex chromosomes did not correspond
with municipally-registered gender.
1.3. Subsample for calculation of the gender index
We conducted the analyses to calculate gender indexes on the
subsample of participants from whom DNA was analyzed. We suspected
that participants with an intersex condition or non-conform gender
identity are more likely to have discrepancies between their psycho-
social and biological sex, thus these were excluded from the analyses to
compose the gender index (Furtado et al., 2012).
We defined intersex conditions as chromosomal variations of the
sex-chromosomes (e.g. Triple-X syndrome); genetic mutation(s) re-
sulting in hormonal disturbances relevant for sexual development (e.g.
congenital adrenal hyperplasia); or extreme variations of internal and/
or external genital organs (e.g. uterus didelphys or micropenis). In line
with previous research, we also included more common variations of
the external organs such as hypospadias, cryptorchism (for which an
operation was needed), uterus anomalies or a vaginal septum as in-
tersex conditions (Blackless et al., 2000). Although such common var-
iations are generally not considered expressions of intersex conditions,
we excluded all participants with any variations in this stereotype ap-
pearance, so that we include the most stereotypic women and men from
a biological viewpoint (see Appendix A.1 for more details).
Complementing approaches were applied to identify participants
with an intersex condition (Appendix A.2). Firstly, the subsample of
participants who's DNA had passed the earlier described quality control
(n = 13,395) was selected, since this selection excluded participants
with copy number variations of the sex chromosomes, SRY-gene ab-
normalities, or participants with an officially changed transgender
identity. Secondly, text fields asking about disorders, birth defects and
operations were searched for expressions of potential intersex varia-
tions, intersex birth defects and sex-related operations, respectively.
Lastly, we considered all biological males who used prescribed estro-
gens and all biological females who used prescribed testosterone
transgender in the current study. Ultimately, 74 participants within the
subsample were labeled as ‘highly likely’ of having an intersex condi-
tion or non-conform gender identity and were excluded (Appendix A.3).
This resulted in a subsample of n = 13,321 to construct a gender index.
1.4. Gender-related variables
All psychological and social variables are included in the model to
construct the gender index, as far as these meet both of the following
criteria: i) the variable is not reflecting a momentary emotional state
that strongly fluctuates over short time periods and ii) the variable
has< 40% missing values. Since the included questionnaires were not
originally constructed to identify potential psychosocial differences
according to sex, potential sex-related differences are more likely to be
found in single items, than in sumscores of questionnaires. Therefore,
we included item-level variables. Only for the NEO-PI-R (Costa and
McCrae, 1992), which assesses personality traits, we included mean
subscale scores, rather than item scores, because we did not expect
individual items to differ more between sexes than subscales would.
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This resulted in 153 variables, consisting of 145 single variables and 8
personality subscales, included in the analyses. These variables cover
three of the four gender aspects which were previously defined, namely
gender roles, gender dynamics and institutionalized gender (Johnson
et al., 2007; Pelletier et al., 2015). Appendix B provides information on
included variables.
1.5. Statistical analyses
1.5.1. Elastic net regularized generalized linear model
Based upon visual inspection of missing data patterns of the adult
Lifelines population with the VIM Package 4.8.0, we concluded that
there is no strong indication of data missing not at random and there-
fore multiple imputation with Mice Package 3.3.0 in R Studio 1.1.383
was performed (van Buuren and Groothuis-Oudshoorn, 2011). Age,
municipally-registered sex and source of entry into the study were al-
ways included as predictor variables for the multiple imputation. In
total, 73% of all participants had at least one missing value on a vari-
able that was relevant to construct the gender index. The variable with
the highest frequency of missing data (20.9% of all participants) was
membership of a social club. The minimal correlation of potential
predictors with the variable to be imputed was 0.1. To construct a
gender index, 245 variables (derived from 153 unique psychosocial
variables potentially related to sex) were entered into an elastic net
regularized generalized linear model with sex as dichotomous outcome
(n = 13,321) (Zou and Hastie, 2005). This method retains parsimo-
nious number of variables, which are highly predictive for the outcome
and attains a high predictive accuracy of the model (Zou and Hastie,
2005; Hastie and Qian, 2014). The data was randomly assigned to a
training set (80%; n = 10,657), and a testing set (20%, n = 2664). The
former set was used to estimate coefficients: larger estimated coeffi-
cients indicate greater importance in discriminating between sexes. The
latter set was used to calculate the model's predictive accuracy. The
optimal regularization parameter α was selected by a grid search with
the same 10-fold cross-validation for three αs, namely 0.1, 0.5 and 1.0.
For the predictive model with the optimal α, the value of λ that mini-
mized the mean squared error (MSE) was selected by 10-fold cross-
validation, as was λ plus one standard error: λ.1se. The area under the
receiving operating characteristic-curve (AUC) was calculated when
predicting classification of participants into ‘male’ or ‘female’ as the
measure of goodness of fit. To provide an overview of the most dis-
criminative gender-related variables, a model with the AUC of 0.80,
generally already interpreted as ‘good’ classifying accuracy, was cal-
culated as well in the test set.
Estimates of the coefficients obtained through the aforementioned
regression ultimately formed the basis of the composite gender index
that was applied to each adult Lifeline participant (n = 152,728). The
gender index is a continuum, ranging from 0% to 100%, representing
the probability of each individual being a woman: the higher the gender
index, the more feminine characteristics a person has. Androgyny is
indicated by an index of 50%, where equal levels of feminine and
masculine characteristics are present.
1.5.2. Analyses of common somatic symptoms and chronic diseases
Previous studies showed that age and educational levels are asso-
ciated with gender roles (Koenig, 2018; Miller and Chamberlin, 2000),
thus we performed two-way ANOVAs to assess whether the magnitude
of difference in gender index between sexes was equal across age
groups (18–44, 45–64, 65+) (Hilderink et al., 2013) and educational
levels (low, medium, high) (van Zon et al., 2017) in the current study.
Twelve multiple ordinal regressions were conducted to investigate
whether sex and the gender index independently have an association
with common somatic symptoms in the general population.
Assumptions of ordinal regression were met (O'Connell, 2006).
Common somatic symptoms were assessed with the 12-item ordinal
Symptom CheckList-90 Somatization subscale (SCL-90 SOM), which has
been recommended for large scale studies (Zijlema et al., 2013). The 12
items had five Likert-response options. We used multiple linear re-
gression to investigate the associations of the gender index and sex with
the SCL-90 SOM sumscore.
To test the associations of sex and the gender index with the lifetime
prevalence of chronic diseases, we performed twelve multiple logistic
regression analyses. Diseases that were identified by the Dutch Ministry
of Health, Welfare and Sport as causing the greatest loss of healthy life
years per person in the Netherlands were identified amongst Lifelines
participants (Dutch Ministry of Health, Welfare and Sports, 2019;
Gijsen et al., 2013; Hoeymans et al., 2013). At baseline, self-reported
lifetime prevalence hereof was measured. Low-prevalent (e.g. de-
mentia) and sex-specific diseases (e.g. pregnancy diabetes) were ex-
cluded from the analyses (Green, 1991). Validity of the logistic re-
gression's linearity assumption was violated for cardiovascular diseases
(CVD; encompassing arrhythmia, heart failures and heart attack), skin
cancer, epilepsy and asthma/COPD. Thus, gender indexes were cate-
gorized into quartiles that were included in the respective models. As a
Table 1
Overview of demographic characteristics of the subsample on which the gender index is based and the complete adult Lifelines cohort at baseline.
Characteristic Subsample Gender index (n = 13,321) Adult Lifelines Cohort (n = 152,728)
Source into study (%) Family 3786 (28.3%) 49,264 (32.5%)
GP 8653 (64.4%) 81,533 (53.4%)
Self-registered 956 (7.1%) 21,571 (14.1%)
Mean age in years (SD) 48.1 (11.4) 44.6 (13.1)
Sex (%) Male 5598 (41.8%) 63,388 (41.5%)
Female 7797 (58.2%) 89,340 (58.5%)
Median gender index (IQR) Male 0.05 (0.01–0.19) 0.06 (0.01–0.24)
Female 0.97 (0.88–0.99) 0.96 (0.83–0.99)
Intersex conditions (%) 74 (0.55%) 1309 (0.86%)
Currently smoking (%) 3113 (23.2%) 32,758 (21.4%)
Alcohol (%) < 1 time a month 4365 (32.6%) 31,195 (20.4%)
1 to 3 times a month 3827 (28.6%) 29,818 (19.5%)
1 to 5 times a week 5240 (39.1%) 75,141 (49.2%)
6 to 7 times a week 1448 (10.8%) 16,574 (10.9%)
Currently in a relationship (%) 11,663 (87.1%) 129,129 (84.5%)
Education (%) No, primary or other education 768 (5.7%) 7380 (4.8%)
Preparatory, vocational or junior secondary education 4381 (32.7%) 41496 (27.2%)
Senior secondary education or higher vocational
education
3885 (29.0%) 48741 (31.9%)
University education 615 (4.6%) 9199 (6.0%)
Median SCL-90 SOM sumscore (IQR) Male 1.17 (1.08–1.42) 1.17 (1.08–1.42)
Female 1.33 (1.09–1.58) 1.33 (1.17–1.58)
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sensitivity analysis, categorization of gender indexes by means of a split
at the median yielded comparable results.
We tested interaction terms between the gender index and sex for
significance. We assessed multicollinearity of the variables by the var-
iance inflation factor (VIF). No problems with multicollinearity were
found, as VIF was< 5 in all analyses. For all the above-mentioned
analyses, we provided analysis codes in OSF (https://osf.io/z9aw4/) to
increase transparency of the study.
2. Results
2.1. The gender index
The gridsearch to select the optimal regularization parameter had
the best binomial deviance and minimal mean-squared errors (MSE)
when α = 1.0, equaling a LASSO regression (Hastie and Qian, 2014).
For the predictive model with α = 1.0, 10-fold cross validation selected
the value of λ that minimized MSE (λ = 9.7E-4; λ.1se = 2.4E-3). This
was the sparsest model, with an accuracy comparable with the best
predictive model. The model's AUC was 92% and the obtained coeffi-
cients were used as the basis for the gender index. Of the initial 245
potentially sex-related variables (representing 153 unique variables),
92 were excluded from the model and 153 (dummy) variables re-
presenting 85 unique variables remained. Many variables were highly
indicative of sex. For reasons of clarity all estimated coefficients of
nominal and ordinal variables with an OR below 0.5 or above 1.5 and
all continuous variables are presented in Appendix C. Most profound
were physical activity-related variables (e.g. type of sport activities),
work-related variables (e.g. profession), lifestyle (e.g. alcoholic uptake),
tasks at home (e.g. cooking and household activities) and personality
characteristics. In the model with an AUC of 80% (α = 1.0; λ = 0.12)
nine variables remained, related to hours of work, hours of household
activities including cooking dinner, and spending leisure time by per-
forming odd jobs (Table 2).
The distribution of the gender index (range: 0–100% feminine) was
bimodal. We found median gender indexes of 0.06 (IQR: 0.01, 0.23) for
men, and 0.96 (IQR: 0.83, 0.99) for women. In 10.1% (n = 15,480) of
the participants the gender index was not in line with their biological
sex: 12.5% (n = 7935) of all men scored 50% or higher on the gender
index (indicating psychosocial femininity), and 8.4% (n = 7545) of all
women scored less than 50% (indicating psychosocial masculinity).
Significant interaction terms in two-way ANOVAs showed that the
magnitude of the difference in gender index between men and women
differed across age groups and educational level, thus analyses were
adjusted for age and education.
We performed our analysis with the gender index that was built
upon a population that excluded people with an intersex condition.
However, many large cohort studies do not include genetic data in
addition to health measures. Thus, participants with intersex conditions
in such cohorts cannot be excluded based on a genetic profile.
Therefore, we also calculated a gender index based on the complete
adult Lifelines population. We found median gender indexes of 0.05
(0.01, 0.22) for men, and 0.97 (0.87, 0.99) for women. A Wilcoxon
Signed Rank test for related samples found no statistically significant
difference for the gender indexes in both men and women Additionally,
the two gender indexes are highly correlated (ρ > 0.95).
2.2. Sex and gender, and the association with common somatic symptoms
Sex and gender (i.e. feminine or masculine characteristics) in-
dependently associated with common somatic symptoms (Table 3).
Significant interaction terms in 9 of the 12 tested symptoms showed
that the association of feminine gender characteristics with common
somatic symptoms significantly differed per sex for the majority of
symptoms. Therefore, we stratified the associations of feminine gender
on the common somatic symptoms per sex. Fig. 1 shows that men's
experiences of the common somatic symptoms are strongly associated
with an increase in feminine gender characteristics. As suggested by all
ORs exceeding 1.0, displaying feminine characteristics is associated
with a higher common somatic symptom burden of all types. For ex-
ample, a one hundred-percent increase in femininity score in men, is
associated with 1.74 times higher odds on experiencing a one-point
increase in severity of dizziness as measured by the SCL-90 SOM. In
women, however, feminine characteristics are associated with less chest
pain and less difficulties in breathing. The association between femi-
nine characteristics and the sumscore of the SCL-90 SOM was sig-
nificantly stronger in men than in women. In men, a one hundred-
percent increase in feminine characteristics is associated with a 0.09-
point increase in the SCL-90 SOM sumscore (β = 0.09; 95% confidence
interval: 0.08,0.10), whereas in women a one hundred-percent increase
in feminine characteristics is associated to a 0.02-point increase in the
SCL-90 SOM sumscore (β = 0.02; 95% confidence interval: 0.01,0.03).
Table 2
Predictors included in the model correctly classifying 80% of the participants’
sex.
Predictor (ordered from strong to less strong) Odds of being a
womana
Always preparing your own dinner 1.30
Days per week light to moderate household activities
(0–7)
1.06
Hours per day light to moderate household activities
(0–16)
1.06
Hours per week working (0–60+) 0.99
Days per week of leisure time spend on odd jobs (0–7) 0.99
Hours of leisure time spend on odd jobs (0–12) 0.96
Sometimes preparing your own dinner 0.80
Dinner is always prepared by someone else 0.65
Spending leisure time on odd jobs of light to moderate
intensity
0.65
a Please note that the odds presented for the continuous predictor variables
are per unit change on the scale of the predictor and are thus not directly
comparable. ORs below 1.0 are indicative of being a male.
Table 3
The adjusted associations of sex and gender with common somatic symptoms.
Predictor Sex - female Gendera - feminine
OR 95% CI OR 95% CI
Outcome
Headache 1.95 1.88, 2.03 1.34 1.28, 1.40
Dizziness 1.61 1.53, 1.69 1.33 1.25, 1.42
Chest pain 0.92 0.86, 0.99 1.01 0.93, 1.10
Lower back pain 1.24 1.20, 1.29 1.09 1.04, 1.14
Nausea 1.49 1.42, 1.56 1.24 1.17, 1.32
Painful muscles 1.29 1.24, 1.34 1.07 1.03, 1.12
Difficulties breathing 1.16 1.09, 1.24 1.02 0.94, 1.10
Feeling hot/cold 3.21 3.05, 3.37 1.24 1.17, 1.31
Numbness or tingling 1.14 1.09, 1.20 1.16 1.09, 1.22
Feeling lump in throat 1.62 1.53, 1.72 1.28 1.20, 1.38
Weakness body parts 1.03 0.99, 1.08 1.38 1.31, 1.46





SCL-90 SOM sumscore 0.09 0.08, 0.10 0.05 0.04, 0.06
NB: The association of sex with common somatic symptoms is adjusted for
gender, age and education, whereas the association of gender with common
somatic symptoms is adjusted for sex, age and education.
a Gender as indicated by the calculated gender index, ranging from 0%
(masculine) to 100% (feminine).
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2.3. Sex and gender, and the association with chronic diseases
Table 4 shows that sex and the gender index have an independent
association with the lifetime prevalence of most chronic diseases. An
increase in gender index, i.e. displaying more feminine characteristics,
is associated with an increased risk of chronic diseases. An example
hereof is the association between a hundred-percent increase in femi-
nine characteristics and the 1.51-times higher odds on having a stroke.
In contrast, female sex appears to be protective of most chronic dis-
eases, except for osteoarthritis, migraine and osteoporosis. Significant
interaction terms in five of 12 tested chronic diseases showed that the
associations of femininity with lifetime prevalence of chronic diseases
significantly differed per sex. Therefore, we stratified the association of
femininity with lifetime prevalence of chronic diseases per sex. Fig. 2
shows that in women increases in gender index appeared to be not
significantly associated with the lifetime prevalence of chronic diseases,
except for migraine (OR = 1.25; 95% confidence interval: 1.16, 1.36).
In men, however, increases in feminine characteristics were found to be
associated with an increased lifetime prevalence of most chronic dis-
eases.
2.4. Sensitivity analyses
To explore the possibility that the associations were identified due
to respondents’ health status, rather than gender roles, a sensitivity
analysis was performed by excluding physical activity-related pre-
dictors. The analysis showed that composition of the gender index re-
mained similar, and was highly correlated to the original gender index
(ρ > 0.95) as well. In addition, the associations of the gender index
without physical activity-related variables with common somatic
symptoms and chronic diseases remained similar to those found with
the original gender index. To explore the influence of the imputations,
we performed a second sensitivity analysis based on respondents with
complete data. The analyses showed that again that the composition of
the gender index remained mostly comparable and was highly corre-
lated to the original gender index (ρ = 0.95). Additionally, the asso-
ciations of the gender index with common somatic symptoms and
chronic diseases remained comparable. Results of both sensitivity
analyses are provided in the electronic supplementary materials.
3. Discussion
We found that a higher gender index (i.e. tending towards feminine
characteristics) and sex are independently associated with common
somatic symptoms and lifetime prevalence of chronic diseases.
Feminine characteristics are associated with experiencing a higher
common somatic symptom burden and chronic diseases, especially in
men. Female sex is also associated with a higher burden of common
somatic symptoms, but not to all chronic diseases, compared to male
sex. In 10.1% of the participants, the gender index was not in line with
participants’ sex, as in 12.5% of men and 8.4% of women a discrepancy
between gender index and sex was found.
Fig. 1. The associations of feminine gender with reported common somatic symptoms, stratified by sex.
Table 4
The adjusted associations of sex and gender with the prevalence of chronic
disease.
Predictor Sex – female Gendera – feminine
OR 95% CI OR 95% CI
Outcome
CVD 0.88 0.82, 0.91 1.17 1.09, 1.26
Epilepsy 0.66 0.57, 0.78 1.60 1.34, 1.91
Asthma/COPD 1.01 0.95, 1.06 1.08 1.02, 1.15
DM1 0.54 0.37, 0.79 1.44 0.91, 2.27
DM2 0.48 0.42, 0.55 1.91 1.61, 2.26
Stroke 0.57 0.46, 0.71 1.51 1.16, 1.97
Osteoarthritis 1.68 1.55, 1.82 1.09 0.98, 1.20
Skincancer 1.16 0.99, 1.35 1.13 0.96, 1.34
Kidney failure 1.08 0.95, 1.22 1.19 1.02, 1.38
Migraine 2.37 2.25, 2.49 1.27 1.19, 1.35
Osteoporosis 4.73 3.89, 5.75 1.07 0.86, 1.33
Rheumatoid arthritis 1.04 0.91, 1.19 1.55 1.32, 1.83
NB: The linearity assumption for logistic regression between gender and CVD,
skin cancer, epilepsy and asthma/COPD was violated. Therefore, results here
are the odds of the highest gender quartile compared to the lowest gender
quartile. The associations of sex with the prevalence of chronic diseases is ad-
justed for gender, age and education, whereas the association of gender with
the prevalence of chronic disease is adjusted for sex, age and education.
a Gender as indicated by the calculated gender index, ranging from 0%
(masculine) to 100% (feminine).
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3.1. Strengths and limitations
This study has some strengths. First, LifeLines includes a large
sample size in which many psychosocial variables were assessed. This
allowed us to incorporate a wide range of gender-related psychosocial
candidate variables into the model. Furthermore, it assured strong
statistical power. Second, the current method of calculating a gender
index follows a data-driven approach, whereas most previously estab-
lished gender indexes follow a theory-driven approach (Bem, 1974;
Lippa and Connelly, 1990; Pelletier et al., 2015; Smith and Koehoorn,
2013). Both approaches have their respective advantages and dis-
advantages. A data-driven approach allows for a model to include a
wide range of psychosocial characteristics to construct a gender index
and to move beyond merely operationalizing gender roles by means of
personality characteristics. Furthermore, it allows to establish a time-
and place-dependent gender index since the index is constructed based
on psychosocial differences between biological sexes in the cohort
under study. In other words, the method is flexible and adaptive and
can be applied to calculate a gender index specific to the study's con-
text. Other studies do not necessarily need to rely on genetic data of
participants to exclude people with indeterminate binary sex, as we
showed that excluding the people with an intersex condition from a
large general population cohort did not change the constructed gender
index significantly. However, one should note that the estimated coef-
ficients are chosen merely based on maximizing predictive accuracy of
a model and the nature of the predictors is ignored. That is, when two
variables are equally contributing to improving the model's predictive
accuracy, the algorithm randomly chooses one of the predictors. Ad-
ditionally, the gender index proposed here is a study-specific measure
for gender roles that cannot be generalized to other studies: although
the method is applicable in other studies, the exact construct of the
gender index will vary across settings.
A theory-driven gender index allows for easier comparison across
studies and its interpretation is more straightforward than that of a
data-driven gender index. However, it should be noted that a theory-
driven gender index cannot handle the time- and place-dependent
nature of (the embodiment of) gender roles, i.e. the relevance of the
index might differ between studies performed at different times or at
different places. Given these advantages and disadvantages of both
approaches, a combination of a theory-driven approach (in which po-
tential gender-related variables are selected based on theory or expert
opinion) and a data-driven approach (in which an algorithm maximizes
the predictive accuracy of the model underlying the gender index) may
yield the easiest interpretable and most trustworthy gender index.
Limitations of the study should be acknowledged as well. First, we
did not include a gold standard gender measure, as this does not exist
yet (Schiebinger and Stefanick, 2016). Thus, our gender index was not
validated with other measures. Second, this study is not gender-ex-
pansive, as it does not move beyond the male/female binary. Therefore,
our results are not directly applicable to agender or non-binary people.
Third, lifetime prevalence of chronic diseases was self-reported, which
could cause response and recall bias. These biases might differ between
women and men. Several studies suggest that men are less willing to
report health problems and report health problems at a later time than
women (Singh-Manoux et al., 2008; Hausteiner-Wiehle et al., 2011),
Therefore, the reported association of female sex -and by inference that
of femininity-with chronic diseases might be an overestimation. Last,
this study had a cross-sectional design, which does not allow for any
causal inference of the effect of gender on common somatic symptoms
or chronic diseases, or vice versa. Therefore, no causality can be con-
cluded from the study. In addition, we cannot exclude the possibility
that the reported associations are partly spurious, since the predictors
on which the gender index is based may not only reflect respondents'
gender roles but also their general health. However, a sensitivity ana-
lyses using a gender index that was estimated without physical activity-
related variables showed that the associations of sex and gender with
health outcomes remained comparable, suggesting that the reported
associations are largely meaningful.
3.2. Sex and gender, and the relation to common somatic symptoms and
chronic disease
To the authors’ knowledge, this is the first study in which gender
indexes were derived in a data-driven manner, i.e. without pre-specified
variables. The defined model displayed 92% accuracy in distinguishing
between sexes, indicating that the included psychosocial variables are
Fig. 2. The associations of feminine gender with reporting chronic diseases, stratified by sex.
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strongly connected to being a man or a woman in the LifeLines Cohort. .
The variables with the highest predictive value for sex (i.e. work-related
and household-related variables, and dedicating leisure time to odd
jobs) in the current study, were in concordance with previous studies
(Lippa and Connelly, 1990; Pelletier et al., 2015; Smith and Koehoorn,
2013). A newly identified variable within the realm of household-re-
lated variables that strongly discriminates between sexes included the
frequency in which one prepares his or her own dinner.
We found that household-related activities had strong predictive
value in discriminating between sexes. A Swedish study found 2.2-fold
higher odds on experiencing common somatic symptoms for women
who had many domestic duties, compared to women with few domestic
duties (Krantz and Ostergren, 2001). Follow-up studies replicated this:
women with jobstrain and domestic duties had higher odds on experi-
encing common somatic symptoms than women with jobstrain and no
domestic duties (Krantz et al., 2005; Mellner et al., 2006). These studies
support the idea that female gender roles are more stressful and less
gratifying than male gender roles, which might lead to worse health
outcomes (Nathanson, 1975). Household responsibilities have been
associated with lower access to health care in both men and women
(Pelletier et al., 2014), suggesting that healthcare factors might explain
health-related gender differences as well. Finally, we cannot exclude
reverse causality, in which experiencing common somatic symptoms
results in less paid working hours and therefore conducting more
household-related activities (van der Leeuw et al., 2015).
Literature on the association of gender with common somatic
symptoms and chronic diseases is scarce. Although many studies do not
explicitly distinguish between sex and gender in health (Regitz-
Zagrosek, 2012; Hankivsky et al., 2018), some studies suggest that
differences in gender roles are mediating sex differences in experienced
health (Robinson et al., 2001; Alabas et al., 2012; Pelletier et al., 2016).
The current study also shows that female sex and feminine gender roles
are independently associated with increased common somatic symp-
toms. Earlier research has shown that female sex is a risk factor for a
variety of symptoms (Barsky et al., 2001; Tomenson et al., 2013). Our
findings show that female sex compared to male sex is associated with
an increased lifetime prevalence of osteoporosis, migraine and os-
teoarthritis, which is in line with previous studies (Hame and
Alexander, 2013; Alswat, 2017; Schroeder et al., 2018). The current
results also suggest that male sex was associated with an increased
prevalence of CVD, which is in line with the traditional, yet increasingly
defeated, idea of CVD being ‘a man's disease’ (Wenger, 2012; Humphries
et al., 2017). However, it must be noted that underdiagnoses of
-amongst others-cardiovascular diseases, still tends to occur in women,
despite improvements made over the last decade (Wenger, 2012). Ad-
ditionally, women might undergo different (diagnostic) care trajec-
tories than men, rendering women with more delayed or wrong diag-
noses (Arber et al., 2004, 2006). This underreporting might partly
explain the protective association of female sex with cardiovascular
disease.
To the authors' knowledge, this is the first study to show that fem-
inine gender is associated with an increased burden of common somatic
symptoms and a higher lifetime prevalence of chronic diseases, espe-
cially in men. This is in line with previous studies that showed that
higher frequencies of common somatic symptoms are reported in
gender dysphoric (i.e. people in whom sex assigned at birth and current
gender identity do not match) and gender non-conforming individuals,
than in cisgender individuals (Heylens et al., 2014; Colizzi et al., 2015;
Serpe, 2017; Shirdel-Havar et al., 2019). More specifically, significantly
higher SCL-90 SOM scores were reported in male-to-female transsexual
and transgender individuals than in cisgender men (Auer et al., 2013).
These increased rates of common somatic symptoms are often attrib-
uted to the psychological distress that is inherent to gender dysphoria.
The inability to adhere to imposed societal norms on masculinity and
femininity is theorized to cause anticipated and internalized stigma in
these individuals, which results in a higher chance of reporting somatic
symptoms (Serpe, 2017). Although the feminine men in our study are
not necessarily gender dysphoric (they merely display more feminine
than masculine characteristics) the psychological distress that accom-
panies the non-adherence to societal norms on gender roles together
with the stress that accompanies female gender roles could have af-
fected these participants as well. Only one previous study amongst the
general population tested whether femininity was associated with
common somatic symptoms. This study found no significant associa-
tion, but had a relatively small sample size and used the BSRI (Castro
et al., 2012). No distinction between sexes was made in this study.
In conclusion, incorporating one's gender roles and sex in care tra-
jectories could aid the process of effective medicine, tailored to the
societal circumstances in which gender roles are shaped. Therefore, we
recommend to conduct further research to explore the effect of gender
on health outcomes in clinical settings. In line with this, research could
focus on the association of gender with established risk factors for
disease, instead of the disease itself, for this might allow for more ef-
fective preventative interventions. Additionally, a longitudinal study
design could be useful to explore possible reverse causality between
gender roles and health and to obtain insight into the relation between
the two concepts. We also suggest to set a stricter distinction between
gender and biological sex in research and literature, as these concepts
are often applied interchangeably. Lastly, we recommend the con-
sideration of gender in large cohort studies, as our methodology shows
this is feasible.
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Appendix A
A.1 Potential Intersex Conditions
Copy number variations of the sex chromosomes
45, X0 46, XX/XY 47, XXY 47, XXX
48, XXXX 48, XXYY 49, XXXXX 49, XXXXY
Genetic mutations
5α-reductase deficiency Congenital adrenal hyperplasia
17β-Hydroxysteroid dehydrogenase deficiency Androgen insensitivity syndrome
Aromatase deficiency Aromatase excess syndrome
Isolated 17,20-lyase deficiency Leydig cell hypoplasia
Lipoid congenital adrenal hyperplasia Swyer Syndrome/Gonadal dysgenesis
Developmental variations of internal and/or external sex organs
Aphallia Diphallia
Micropenis Cryptorchism
Müllerian agenesis (MRKH syndrome) Clitoromegaly
Pseudovaginal perineoscrotal hypospadias Uterus didelphys
Uterus unicornis Additional uterine anomalies
Aposthia Hypospadias
A.2 Sampling method
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A.3 Number of participants with potential intersex and/or non-conform gender identity, within the complete Lifelines sample and the subsample from whom
DNA passed quality control








Congenital adrenal hyperplasia 8 0
Congenital variations of internal and/or external sex organs
Hypospadia 53 3
Cryptorchisma 1106 64
Operated for dysplastic or divergent sex organsb 42 2
Primary hypogonadism 10 0
Ovarian tube(s) missing or underdeveloped 7 0
Uterine anomalies 28 3
Müllerian agenesis (MRKH syndrome) 11 1
Gonadal dysgenesis (Swyer syndrome) 1 0
Non-conform gender identity
Expressed gender dysphoria or non-conform gender identity and/or transgender medication use and/or transsexual
operation(s)
19 1c
Total 1309 (0.86%) 74 (0.55%)
a Cryptorchism included if present at adult age and/or reported as operated:99% of the 1106 participants who reported cryptorchism, reported it as operated.
b e.g. “no vagina”, “vaginal septum”, “divergent sex organs adjusted”.
c The participant informed the researchers of the change in sex in the municipal registration and was thus not excluded during the quality control procedures of the
genetic material.
Appendix B. –Categories of variables included in LASSO regression
Categories
1 General information and demographics
2 Current and past relationships
3 Living situation
4 Education and work
5 Social activities and wellbeing
6 Lifestyle
7 Diet and weight beliefs
8 Threatening experiences and long-term difficul-
ties
9 Personality (NEO-PI-R)
Note: Detailed information on the included variables are included as electronic
supplementary material.
Appendix C. Nominal and ordinal predictors (odds > 1.5 or < 0.5) and all continuous predictors in the model with 92% predictive
ability of the participants' sex
Nominal and ordinal predictors (ordered from strong to less strong) Odds of being a woman
Performing sport activity: horseriding 6.89
Performing sport activity: zumbaa 5.58
Performing sport activity: soccer 0.19
Profession: crafts and related trades workers 0.21
Always preparing your own dinner 4.34
Being retired 0.26
Drinking alcohol 6–7 days a week 0.27
Doing leisure time odd jobs of moderate intensity 0.28
Dinner is always prepared by someone else 0.32
Drinking alcohol 3 days a week 0.32
Profession: plant and machine operators and assemblers 0.32
Currently in a job 2.99
Being a housewife or househusband 2.82
Short period of time dieting 2.56
Drinking alcohol 4–5 days a week 0.40
Doing leisure time odd jobs of light intensity 0.41
Drinking alcohol 1 day a week 0.42
Profession: skilled agricultural, forestry or fishery workers 0.44
Performing sport activity: gymnastics 2.26
Often preparing your own dinner 2.15
Losing one's job and not able to find new work 1.99
Profession: services and sales workers 1.77
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Unpleasant experience: got in trouble with the law or police in the past year 1.73
Profession: clerical support workers 1.55
Performing sport activity: swimming 1.54
Experienced difficulties and stress in the relationship with ones parents 1.53
Continuous predictors (odds per unit change on respective scale)
Higher mean scores on the self-discipline scale of the NEO (range: 0–4)b 1.52
Higher mean scores on the impulsiveness scale of the NEO (range: 0–4)b 1.38
Higher mean scores on the self-consciousness scale of the NEO (range: 0–4)b 1.38
Number of household members smoking (range: 0–6+) 1.29
Hours per day light to moderate household activities (range: 0–16) 1.29
Higher mean scores on the vulnerability scale of the NEO (range: 0–4)b 1.29
Hours per day vigorous household activities (range: 0–16) 1.25
Hours sleep per 24 h (range: 4–20) 1.19
Days per week light to moderate household activities (range: 0–7) 1.13
Higher scores on the competence scale of the NEO (range: 0–4)b 1.08
Days per week light to moderate household activities (range: 0–7) 1.04
Number of times moved house (range: 0–25+) 1.01
Percent declared unfit for work (range: 0–100%) 0.99
Days per week walking (range: 0–7) 0.98
Days per week at least 30 min light to moderate work (range: 0–7) 0.97
Number of cigars smoked per day (range: 0–10+) 0.97
Hours per day light to moderate work (range: 0–16) 0.96
Hours per week volunteering (range: 0–60) 0.95
Hours per week working (range: 0–60) 0.94
Number of co-residents (range: 0–6+) 0.93
Hours per day TV-watching (range: 0–8) 0.92
Hours per day cycling (0–12) 0.90
Higher mean scores on the deliberation scale of the NEO (range: 0–4)b 0.88
Hours per day odd jobs (range: 0–12) 0.86
Days of the week odd jobs (range: 0–7) 0.85
Higher mean scores on the hostility scale of the NEO (range: 0–4)b 0.80
Higher mean scores on the excitement scale of the NEO (range: 0–4)b 0.51
NB: An OR below 1.0 indicates being a man.
a Zumba is dance-based type of fitness.
b Mean subscale scores of the NEO-PI-R.
Appendix D. Supplementary data
Supplementary data to this article can be found online at https://doi.org/10.1016/j.socscimed.2020.112968.
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